Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/16/2026

Pathophysiology and Clinical Manifestations of Tetanus

Causative Organism and Toxin Production

  • Clostridium tetani is a ubiquitous, spore-forming, motile Gram-positive anaerobic bacillus found in high concentrations in soil and animal excrement, and the spores enter the body through breaches in the skin or mucous membranes 1, 2
  • Germination of spores occurs only under anaerobic conditions, such as in necrotic tissue resulting from deep puncture wounds or blunt trauma 1, 3, 4
  • Once germinated, C. tetani bacilli vegetate and produce tetanospasmin, a powerful exotoxin that binds irreversibly with neural tissue 1, 2

Temporal Progression and Mortality

  • The incubation period from injury to symptom onset varies from 3 to 21 days (median: 7 days), with extremes of 1 day to several months, and shorter incubation periods are associated with more severe disease and poorer prognosis 3, 2, 5
  • The case-fatality ratio can be as high as 100% without high-quality medical care, but remains approximately 10-20% even in modern healthcare facilities, and is highest in infants and the elderly 3, 2, 5

Toxin Mechanism and Clinical Implications

  • Tetanospasmin prevents the release of inhibitory neurotransmitter gamma-aminobutyric acid (GABA) in the spinal cord, brainstem motor nuclei, and the brain, producing muscle rigidity and tonic spasms of skeletal muscles 1
  • The irreversible binding of tetanospasmin to neural tissue is the key pathophysiologic feature that explains why treatment focuses on neutralizing circulating toxin before it binds, rather than reversing already-bound toxin 1, 3

Pathophysiology and Clinical Consequences of Tetanus

Transmission and Entry

  • Environmental spores of Clostridium tetani penetrate the body through breaches of skin or mucous membranes (e.g., puncture wounds, lacerations, abrasions, burns, surgical sites, and neonatal umbilical stumps) — CDC recommendation 6.

  • Tetanus is a non‑communicable vaccine‑preventable disease, meaning it cannot be transmitted person‑to‑person — CDC recommendation 6.

Germination and Toxin Production

  • Spore germination occurs exclusively under anaerobic conditions, such as in necrotic tissue of deep puncture wounds or blunt trauma where oxygen is limited — CDC recommendation 6.

  • After germination, vegetative bacilli synthesize tetanospasmin, a highly lethal neurotoxin regarded as one of the most potent biological toxins known — CDC recommendation 6.

Neuromuscular Effects of Tetanospasmin

  • Inhibition of GABA and glycine release leads to muscle rigidity and tonic spasms of skeletal muscles — CDC recommendation 6.

  • Generalized tetanus typically begins with trismus (“lockjaw”), followed by widespread rigidity caused by painful skeletal‑muscle contractions — CDC recommendation 6.

Respiratory and Autonomic Complications

  • Progressive involvement of respiratory muscles can impair ventilation, increasing the risk of respiratory failure — CDC recommendation 6.

  • Life‑threatening complications include glottic spasm, respiratory failure, and autonomic instability (sympathetic overactivity), which may result in death — CDC recommendation 6.

REFERENCES

5

Tetanus Clinical Presentation and Management [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025